These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 10400761

  • 1. Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.
    Barnett A, Mustafa F, Wrona TJ, Lozano M, Dudley JP.
    J Virol; 1999 Aug; 73(8):6634-45. PubMed ID: 10400761
    [Abstract] [Full Text] [Related]

  • 2. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
    Xu L, Wrona TJ, Dudley JP.
    Virology; 1996 Jan 15; 215(2):113-23. PubMed ID: 8560758
    [Abstract] [Full Text] [Related]

  • 3. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
    Waanders GA, Lees RK, Held W, MacDonald HR.
    Eur J Immunol; 1995 Sep 15; 25(9):2632-7. PubMed ID: 7589137
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
    Wrona TJ, Lozano M, Binhazim AA, Dudley JP.
    J Virol; 1998 Jun 15; 72(6):4746-55. PubMed ID: 9573239
    [Abstract] [Full Text] [Related]

  • 6. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ, Novick MB, Palmer LD, Knepper JE.
    J Immunol; 1993 Feb 15; 150(4):1422-8. PubMed ID: 8094408
    [Abstract] [Full Text] [Related]

  • 7. Chronic deletion, escape from deletion and activation of mouse mammary tumor virus superantigen-reactive T cells in C57BL/10 mice.
    Dyson PJ, Elliott JI.
    Eur J Immunol; 1999 May 15; 29(5):1456-66. PubMed ID: 10359099
    [Abstract] [Full Text] [Related]

  • 8. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY, Jouvin-Marche E, Marche PN, MacDonald HR, Acha-Orbea H.
    Eur J Immunol; 1995 Mar 15; 25(3):857-62. PubMed ID: 7705418
    [Abstract] [Full Text] [Related]

  • 9. Synchronous deletion of Mtv-superantigen-reactive thymocytes in the CD3(medium/high) CD4(+)CD8(+) subset.
    Sheard MA, Sharrow SO, Takahama Y.
    Scand J Immunol; 2000 Dec 15; 52(6):550-4. PubMed ID: 11119259
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. C3H mouse mammary tumor virus superantigen function requires a splice donor site in the envelope gene.
    Mustafa F, Lozano M, Dudley JP.
    J Virol; 2000 Oct 15; 74(20):9431-40. PubMed ID: 11000212
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
    Penninger JM, Wallace VA, Timms E, Mak TW.
    Eur J Immunol; 1994 May 15; 24(5):1102-8. PubMed ID: 8181521
    [Abstract] [Full Text] [Related]

  • 15. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus.
    Held W, Waanders GA, MacDonald HR, Acha-Orbea H.
    Int Immunol; 1994 Sep 15; 6(9):1403-7. PubMed ID: 7819149
    [Abstract] [Full Text] [Related]

  • 16. Characterization of two infectious mouse mammary tumour viruses: superantigenicity and tumorigenicity.
    Buggiano V, Goldman A, Nepomnaschy I, Bekinschtein P, Berguer P, Lombardi G, Deroche A, Francisco MV, Piazzon I.
    Scand J Immunol; 1999 Mar 15; 49(3):269-77. PubMed ID: 10102644
    [Abstract] [Full Text] [Related]

  • 17. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus.
    Waanders GA, Shakhov AN, Held W, Karapetian O, Acha-Orbea H, MacDonald HR.
    J Exp Med; 1993 May 01; 177(5):1359-66. PubMed ID: 8386743
    [Abstract] [Full Text] [Related]

  • 18. Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function.
    Held W, Waanders GA, Acha-Orbea H, MacDonald HR.
    J Exp Med; 1994 Dec 01; 180(6):2347-51. PubMed ID: 7525852
    [Abstract] [Full Text] [Related]

  • 19. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
    Golovkina TV, Dudley JP, Ross SR.
    J Immunol; 1998 Sep 01; 161(5):2375-82. PubMed ID: 9725233
    [Abstract] [Full Text] [Related]

  • 20. [Coevolutive mechanisms between retroviruses and their hosts. The murine mammary tumor model].
    Nepomnaschy I, Buggiano V, Goldman A, Piazzon I.
    Medicina (B Aires); 1997 Sep 01; 57(2):235-44. PubMed ID: 9532836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.